SCHEMBL6665895

SCHEMBL6665895

CCCCCCc1cc2c(cc1C(C)=O)C(C)(C)CCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 7/20 0.44
HNF4A P41235 2/20 0.44
RARA P10276 4/20 0.38
RARB P10826 4/20 0.38
RARG P13631 4/20 0.38
CYP26A1 O43174 1/20 0.38
CYP26B1 Q9NR63 1/20 0.38
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
KMT2A Q03164 2/20 0.35
ALOX5 P09917 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAP3K14 Q99558 1/20 0.34
PTGS2 P35354 1/20 0.34
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6669480 0.99 RXRA (0.45) RXRAHNF4ARARARARBRARG
SCHEMBL6665724 0.95 RXRA (0.46) RXRAHNF4ARARARARBRARG
SCHEMBL6668009 0.90 RXRA (0.47) RXRAHNF4ARARARARBRARG
SCHEMBL9850259 0.89 RXRA (0.50) RXRAHNF4ARARARARBRARG
SCHEMBL6668058 0.86 RXRA (0.50) RXRAHNF4ARARARARBRARG
SCHEMBL8864927 0.81 RXRA (0.37) RXRAKDM4EALDH1A1KMT2AALOX5
SCHEMBL9850143 0.80 RXRA (0.53) RXRAHNF4ARARARARBRARG
SCHEMBL8865353 0.80 RXRA (0.38) RXRAKDM4EALDH1A1KMT2AALOX5
SCHEMBL9850319 0.78 RXRA (0.43) RXRAHNF4ARARARARBRARG
SCHEMBL6910130 0.78 RXRA (0.62) RXRAHNF4ARARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0785782-B1 USE OF DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN INC (US) 2004-09-08 EP disclosed
US-5602130-A ORNITHINE DECARBOXYLASE ENZYME INHIBITOR TREATING SKIN DISORDER, INHIBITING CELL HYPERPROLIFERATION ALLERGAN 1997-02-11 US disclosed
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US disclosed
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
US-5348972-A In treatment of skin disorders such as acne and psoriasis ALLERGAN, INC. (US) 1994-09-20 US disclosed
US-5234926-A Skin disorders ALLERGAN, INC. (US) 1993-08-10 US disclosed
EP-0284288-B1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1992-05-27 EP disclosed
US-5089509-A Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC. (US) 1992-02-18 US disclosed
CN-88101424-A Substituted acetylenes with retinoid like activity and containing heteroaromatic and heterobicyclic groups and process for preparation thereof 1988-10-05 CN disclosed
EP-0284288-A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed